Company will use novel, patented Klotho Gene (s-KL) in studies New York, NY, September 4, 2024 - PRISM MediaWire - ANEW MEDICAL, INC. (NASDAQ: WENA), a U.S. biotechnology company, announced that it has two distinct goals for its pioneering cell and gene therapy development. One is to enhance the potential of people achieving a healthy long life, and the other is the development of effective treatments for age-related disorders and neurodegenerative diseases such as ALS, Alzheimer’s and...
![Healthy Longevity is One of Key Development Goals of ANEW’s Novel Gene Therapy](https://prismmediawire.com/wp-content/uploads/2024/08/Newsroom-4-1080x675.png)